Dow Up0.08% Nasdaq Down0.30%

Elite Pharmaceuticals, Inc. (ELTP)

-OTC BB
0.33 Down 0.01(2.96%) Sep 19, 3:46PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Mar 31, 2013Mar 31, 2012
Total Revenue 4,601   3,404   2,424  
Cost of Revenue3,236  2,315  1,014  
Gross Profit 1,365   1,088   1,410  
Operating Expenses
Research Development3,959  975  1,736  
Selling General and Administrative2,189  1,559  1,435  
Non Recurring -   -   -  
Others501  117  206  
Total Operating Expenses -   -   -  
Operating Income or Loss (5,284) (1,563) (1,966)
Income from Continuing Operations
Total Other Income/Expenses Net(90,684)3,090  (12,922)
Earnings Before Interest And Taxes(95,968)1,527  (14,888)
Interest Expense900  393  654  
Income Before Tax(96,868)1,134  (15,542)
Income Tax Expense(293)(354)(484)
Minority Interest -   -   -  
Net Income From Continuing Ops(96,575)1,488  (15,058)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (96,575) 1,488   (15,058)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (96,575) 1,488   (15,058)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.